JUVEDERM HYALURONATE GEL IMPLANTS
FDA premarket approval P050047/S031 · decided 2013-11-26
Approval details
- PMA number
- P050047
- Supplement
- S031
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- JUVEDERM HYALURONATE GEL IMPLANTS
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Allergan
- Date received
- 2013-08-03
- Decision date
- 2013-11-26
- Days to decision
- 115 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- APPROVAL FOR CHANGE TO THE CONCENTRATION OF THE LIDOCAINE SOLUTION INTRODUCED TO THE GEL DURING THE HOMOGENIZATION STEP FROM 50% W/W TO 30% W/V LIDOCAINE HYDROCHLORIDE AND A REVALIDATION, BY WEIGHT, THE AMOUNT OF GEL THAT CAN BE MIXED DURING THE HOMOGENIZATION STEP OF THE MANUFACTURING PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229) | Allergan | 2021-06-02 |
| TrueTear Intranasal Tear Neurostimulator (K193589) | Allergan | 2020-08-31 |
| Natrelle 133 Plus MICROCELL Tissue Expander (K180826) | Allergan | 2018-12-21 |
| Natrelle 133S Tissue Expander (K182054) | Allergan | 2018-08-29 |
| TrueTear Intranasal Tear Neurostimulator (DEN170086) | Allergan | 2018-05-17 |
| SERI SURGICAL SCAFFOLD (K123128) | Allergan | 2013-04-25 |